Keywords
proliferation
Ciliary metaplasia
P16
How to Cite
Abstract
Metaplasia is an adaptive process in which one tissue is transformed into another tissue that is functionally and morphologically different. The most common type of metaplasia in the endometrium is ciliary/tubal metaplasia, which is also common in the cervix, where it is most often located in the transition zone. Ciliary metaplasia of the endometrium is often described in combination with excessive estrogen expression, and its association with simple and complex hyperplasia and highly differentiated adenocarcinoma is also worth noting. Overall, the study included a total of 315 unfixed formalin-fixed and paraffin-embedded (FFPE) cases (normal endometrium n=45; endometrial polyp n=45; simple endometrial hyperplasia n=45; complex endometrial hyperplasia n=45; atypical endometrial hyperplasia n=45). ; endometrioid carcinoma n=45; serous carcinoma n=45;). As can be seen from the data of our studies, ciliary metaplasia, as well as atypical ciliary metaplasia, is characterized by a different expression of estrogen receptors from the main research groups, which indicates hormone sensitivity independent of the main research nosology, which can also be evaluated as a justification for the existence of ciliary metaplasia independent of the main nosologies. As can be seen from the results, ciliary metaplasias show a different proliferative activity from the main study group, which should be taken into account in the algorithm for the evaluation of precancerous processes and tumors of endometrial hyperplasias. P16 can be used as an additional marker of possible progression of endometrial atypical hyperplasia to carcinoma in combination with other parameters.
References
Little, L. & Stewart, C. J. R. Cyclin D1 immunoreactivity in normal endocervix and diagnostic value in reactive and neoplastic endocervical lesions. Mod Pathol 23, 611–618 (2010).
D’Angelo, E. et al. Atypical Endometrial Hyperplasia, Low-grade: ‘much ADO about Nothing’. American Journal of Surgical Pathology 45, 988–996 (2021).
Lax, S. F. [Precursor lesions of endometrial carcinoma]. Pathologe 40, 13–20 (2019).
McCluggage, W. G. Mullerian adenosarcoma of the female genital tract. Adv Anat Pathol 17, 122–129 (2010).
Stringfellow, H. F. & Elliot, V. J. Endometrial metaplasia. Diagn Histopathol 23, 303–310 (2017).
Nicolae, A., Preda, O. & Nogales, F. F. Endometrial metaplasias and reactive changes: A spectrum of altered differentiation. J Clin Pathol 64, 97–106 (2011).
Travaglino, A. et al. Endometrial Metaplastic/Reactive Changes Coexistent with Endometrial Hyperplasia and Carcinoma: A Morphological and Immunohistochemical Study. Diagnostics (Basel) 12, (2021).
Hou, J. Y., McAndrew, T. C., Goldberg, G. L., Whitney, K. & Shahabi, S. A clinical and pathologic comparison between stage-matched endometrial intraepithelial carcinoma and uterine serous carcinoma: Is there a difference? Reproductive Sciences 21, 532–537 (2014).
Apostolou, G. et al. Cytodiagnosis of endometrial carcinoma and hyperplasia on imprint smears with additional immunocytochemistry using Ki-67 and p53 biomarkers. Cytopathology 25, 86–94 (2014).
Apostolou, G. et al. Utility of Ki-67, p53, Bcl-2, and Cox-2 biomarkers for low-grade endometrial cancer and disordered proliferative/benign hyperplastic endometrium by imprint cytology. Diagn Cytopathol 42, 134–142 (2014).
Simon, R. A. et al. Tubal metaplasia of the endometrium with cytologic atypia: analysis of p53, Ki-67, TERT, and long-term follow-up. Modern Pathology 2011 24:9 24, 1254–1261 (2011).
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2024 Georgian Scientists